Nektar Therapeutics | NKTR - 販売および管理費





販売および管理費 変化する 日付
Agios Pharmaceuticals USD 51.55M 13.09M 2026-06
ALKERMES USD 190.54M 6.1M 2026-09
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Amgen USD 1.68B 40M 2026-09
Baxter International USD 730M 5M 2026-09
BioCryst Pharmaceuticals USD 63.98M 31.8M 2026-06
Biogen USD 752M 42.3M 2026-09
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Cara Therapeutics USD 2.09M 96K 2026-03
Cipla INR 13.25B 101.8M 2025-12
Dr.Reddys Laboratories INR 26.1B 11.63B 2026-06
Eisai JPY 114.83B 4.71B 2026-06
Eli Lilly USD 3.12B 305M 2026-09
Exelixis USD 154.56M 6.93M 2026-09
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
Grifols EUR 320.45M 12.65M 2025-12
Halozyme Therapeutics USD 57M 10.71M 2026-06
Incyte USD 364.27M 12.54M 2026-09
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
Karyopharm Therapeutics USD 10.42M 861K 2026-03
MacroGenics USD 7.9M 1.81M 2026-06
Merck USD 2.86B 25M 2026-09
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Neurocrine Biosciences USD 366.3M 16.8M 2026-09
Novartis USD 3.08B 163M 2026-09
Pfizer USD 3.28B 132M 2026-09
Roche Holding CHF 6.37B 908M 2026-06
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
Takeda JPY 271.71B 14.8B 2026-09
Teva Pharmaceutical Industries USD 1.01B 27M 2026-09
Xencor USD 71.93M 5.61M 2026-09